Results 231 to 240 of about 79,953 (279)

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System. [PDF]

J Clin Oncol
Khwaja J, Kirkwood AA, Milani P, Yohannan B, Theodorakakou F, Weverling F, Di Simone V, Ravichandran S, Kumar S, Petropoulos I, Mussinelli R, Cohen O, Oerlemans MIFJ, Muchtar E, Stamatelopoulos K, Lachmann HJ, Gillmore JD, Briasoulis A, Gertz M, Whelan C, Venneri L, Fontana M, Mahmood S, Schwotzer R, Minnema MC, Dispenzieri A, Palladini G, Kastritis E, Wechalekar A.   +28 more
europepmc   +1 more source

Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy

Journal of the Peripheral Nervous System, Volume 31, Issue 1, March 2026.
ABSTRACT Background and Aims In individuals with hereditary transthyretin amyloidosis (ATTRv) polyneuropathy, monitoring of disease progression and treatment response is crucial. The objective is to determine if serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) are reliable biomarkers of ATTRv polyneuropathy ...
Valentin Loser, Pascal Benkert, Alex Vicino, Nicolas Ghika, Pansy Lim Dubois Ferrière, Chantal Daigneault, Thierry Kuntzer, Aleksandra Maleska Maceski, Jens Kuhle, Marie Théaudin   +9 more
wiley   +1 more source

Navigating Diagnostic Ambiguities in Cardiac Amyloidosis: Insights from a Case with Delayed Diagnosis of AL Amyloidosis. [PDF]

Am J Case Rep
Al Hazzouri A, Daou RM, Attieh P, Ibrahim Z, Ghadieh HE, Harbieh B.   +5 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 14 No. 3 [PDF]

, 1978

core   +1 more source

CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response

Journal of the Peripheral Nervous System, Volume 31, Issue 1, March 2026.
ABSTRACT Background and Aims Monoclonal gammopathy of undetermined significance (MGUS) occurs in some patients with chronic inflammatory demyelinating polyneuropathy (CIDP), but its impact on clinical phenotype and treatment response remains unclear.
R. van Veen, A. E. Baars, I. N. van Doorn, M. Michael, S. R. M. Bus, M. C. Broers, W. L. van der Pol, P. A. Van Doorn, J. Drenthen, C. Verhamme, J. M. I. Vos, I. N. van Schaik, H. S. Goedee, L. Wieske, B. C. Jacobs, F. Eftimov, for the ICOS Consortium   +16 more
wiley   +1 more source

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis. [PDF]

Br J Haematol
Khwaja J, Ravichandran S, Cohen O, Foard D, Low M, Martinez-Naharro A, Venneri L, Fontana M, Hawkins PN, Gillmore J, Lachmann HJ, Whelan C, Mahmood S, Wechalekar A.   +13 more
europepmc   +1 more source

Selective RyR2 inhibition reduces arrhythmia susceptibility in human cardiac slices

The Journal of Physiology, Volume 604, Issue 5, Page 1809-1819, 1 March 2026.
Abstract figure legend ent‐Vert selectively inhibits RyR2‐mediated sarcoplasmic reticulum (SR) Ca2+ leak and prevents triggered activity in human cardiac slices. A, in human ventricular slices exposed to β‐adrenergic stimulation with Iso and RyR2 sensitization with caffeine, RyR2 channels become hyperactive, leading to Ca2+ sarcoplasmic leak and ...
Micah K. Madrid, Katy A. Trampel, Batool Salman, Sharon A. George, Tatiana Efimova, Bjorn Knollmann, Igor R. Efimov   +6 more
wiley   +1 more source

Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy. [PDF]

QJM
Kashio T, Horino T, Yagyu K, Osakabe Y, Inotani S, Terada Y.   +5 more
europepmc   +1 more source

Alpha‐Actinin‐3 Deficiency Links Genetic Susceptibility to Renal Fibrosis: Evidence From Hemodialysis Patients and Murine Models

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
This study links the ACTN3 R577X polymorphism to chronic kidney disease (CKD), specifically in patients undergoing hemodialysis (HD). In parallel, increased Actn3 expression in murine models of kidney injury supports a functional role for ACTN3 in renal pathophysiology.
Raisa B. Santos, Hellena Storch Vieira, Alice K. Scheer, Larissa R. Ribeiro, Cledia F. Silva, Rafael B. Orcy, Ines Schadock, Alexandre Budu, Ronaldo Carvalho Araujo, Augusto Schneider, André F. Rodrigues, Michael Bader, Maristela Böhlke, Carlos Castilho Barros   +13 more
wiley   +1 more source

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study. [PDF]

Blood Adv
Song A, Mellgard G, Bellofiore C, Basset M, Nuvolone M, Foli A, Merlini G, Maurer MS, Mapara MY, Bhutani D, Lentzsch S, Shaish H, Palladini G, Chakraborty R, Milani P.   +14 more
europepmc   +1 more source